Status:
COMPLETED
Erector Spinae Plane Block
Lead Sponsor:
Theodor Bilharz Research Institute
Conditions:
Post Operative Pain
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
PHASE3
Brief Summary
Erector spinae plane block (ESPB) is a relatively new plane block that was first described by Forero et al. in 2016, to manage persistent neuropathic pain following malunited rib fracture and persiste...
Detailed Description
This is a prospective randomized controlled study which will be conducted in the Anesthesiology Department at Theodor Bilharz Research Institute after approval by the institutional review board and ob...
Eligibility Criteria
Inclusion
- Patient is able to provide a written informed consent.
- ASA I-II.
- Patient is scheduled to perform an elective open renal surgery through a flank incision.
Exclusion
- ASA III-IV
- Pregnancy.
- Patient is allergic to bupivacaine local anesthetic.
- Impaired coagulation (Platelet count\< 150,000 cells/mcl and/or INR ≥ 1.4).
- Infection at site of injection.
- Prior same side flank surgery.
Key Trial Info
Start Date :
October 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2021
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04118101
Start Date
October 25 2019
End Date
February 15 2021
Last Update
April 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Theodor Bilharz research institute
Cairo, Egypt, 02